中慧生物-B申请H股全流通

Core Viewpoint - Zhonghui Biotech-B (02627) has submitted an application to the China Securities Regulatory Commission for the conversion of 81.662 million unlisted shares into H-shares and for the listing of these shares on the Hong Kong Stock Exchange [1] Group 1 - The company plans to convert a total of 81.662 million unlisted shares into H-shares [1] - The application for the conversion and listing has been submitted to the China Securities Regulatory Commission [1] - The listing is intended to take place on October 15, 2025 [1]